A 51-year-old man — let's call him a representative version of a patient I see most weeks — sat across from me at a sexual wellness consultation last fall. He was about thirty pounds over what he considered his fighting weight, working a demanding job in Warner Robins, sleeping six hours a night, and running on coffee. His complaint was the one men in his demographic find hardest to bring up: his libido had been steadily fading for the past three years and his erections were softer and less reliable than they used to be. His marriage was good. His relationship with his wife was good. He was not depressed in any clinical sense. He just was not interested in sex the way he used to be, and when he was, his body was not cooperating.
His primary care doctor had drawn a single total testosterone three months earlier — 380 ng/dL — and told him he was "in the normal range" and that this was probably just part of getting older. He left that appointment feeling dismissed. He arrived at my office because he did not believe that explanation, and he was right not to.
When I evaluate a man for testosterone-related sexual concerns, the picture is almost never as simple as the total testosterone number on a single lab report. A normal-range total testosterone tells you almost nothing in isolation. The question is whether the bioavailable testosterone is reaching the tissues that depend on it, whether the rest of the endocrine system is supporting or undermining that signal, and whether the patient has other physiological contributors — vascular, metabolic, pharmacological — that need attention in parallel. Treating one part of that picture and ignoring the rest is the most common reason TRT disappoints men who try it.
What testosterone actually does for sexual function
Testosterone supports sexual function through several distinct mechanisms, and recognizing which mechanism is failing in a given patient determines what the protocol needs to do.
The first is libido itself — desire, the cognitive and emotional interest in sex. This is the most testosterone-dependent piece. Central androgen receptors in the brain regulate sexual motivation, and when free testosterone falls below a certain threshold (which varies by patient but tends to cluster in the lower third of the reference range), libido drops. Patients describe it as a quiet absence rather than a problem — they simply do not think about sex the way they used to. This is the symptom most likely to respond clearly to testosterone restoration when low-T is genuinely the driver.
The second is erectile tissue health — the maintenance of the corpus cavernosum smooth muscle, the responsiveness of the cavernosal vasculature, and the integrity of the endothelial nitric oxide pathway. Testosterone supports all three. Long-term low testosterone produces measurable changes in erectile tissue that are not immediately reversible and that contribute to the difficulty some men have getting full benefit from PDE5 inhibitors when their hormone status has been ignored.
The third is the broader physiologic environment — energy, sleep quality, mood, body composition, motivation. None of these are directly sexual, but all of them affect sexual function indirectly. The man with low energy, fragmented sleep, and rising visceral fat is rarely going to feel sexually engaged regardless of what his erections are doing.
The fourth, and the one most often missed: vascular health. As I have written elsewhere, the cavernosal arteries are among the smallest in the body, and they are often the first place systemic endothelial dysfunction shows up clinically. A man whose ED has a substantial vascular contributor will not respond fully to testosterone alone because the substrate of the response — healthy small-vessel function — has been compromised.
Why "normal-range" testosterone often is not normal for the patient
The reference range for total testosterone in most labs runs from approximately 264 to 916 ng/dL. The lower bound of that range was set decades ago using a population that included many men who were already symptomatic and undiagnosed. A total testosterone of 290 is technically "in range" and symptomatically functional in roughly nobody.
The more useful number is free testosterone — the unbound fraction that is biologically active. Free testosterone depends on total testosterone and on SHBG, the binding protein that escalates with age, with insulin resistance, with thyroid changes, and with several common medications. The man whose total testosterone is 380 with an SHBG of 65 nmol/L and a free testosterone of 5.8 ng/dL is functionally hypogonadal at the tissue level even though his total testosterone reads normal. This is the picture I see most weeks. The single total testosterone number missed it. The full panel reveals it.
In my practice, the labs I draw before any TRT decision include total testosterone, free testosterone (calculated and where indicated direct), SHBG, estradiol (sensitive assay), LH, FSH, prolactin, full thyroid panel including reverse T3, fasting insulin, HbA1c, lipid panel with ApoB, hs-CRP, and a complete metabolic panel. A comprehensive workup is what the conversation deserves.
What I look for in patient selection
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
When I evaluate someone for testosterone optimization with sexual function as the primary complaint, several questions shape what I recommend:
How long has the symptom been present, and is the trajectory consistent with hormonal decline (gradual onset over months to years) or with an acute event (sudden onset suggesting a different mechanism)? What is the rest of the symptom cluster — energy, sleep, mood, cognitive function, body composition, exercise capacity? A complete cluster strongly supports a hormonal contributor. An isolated sexual complaint with everything else preserved usually points elsewhere.
What does the lab picture actually show? Genuinely low free testosterone, elevated SHBG without an obvious medication cause, suppressed LH suggesting secondary hypogonadism, elevated prolactin, abnormal thyroid — each finding shapes the protocol differently. A man with primary hypogonadism (low testosterone with elevated LH) needs a different approach than a man with secondary hypogonadism (low testosterone with low LH), and both differ from the man whose testosterone is technically adequate but whose SHBG is suppressing bioavailability.
What is happening with the rest of the cardiovascular and metabolic picture? Insulin resistance, elevated inflammatory markers, central adiposity, sleep apnea — all of these contribute to both sexual symptoms and to the cardiovascular trajectory. Addressing them in parallel matters as much as the testosterone protocol itself.
What medications is the patient on? SSRIs, beta-blockers, finasteride, certain antihypertensives, and chronic opioid therapy all affect sexual function and sometimes affect testosterone directly. A clean medication review changes the plan.
What is the patient looking for, and what is realistic? Men with three years of symptomatic low-T and rising visceral fat will not feel like their 28-year-old selves on testosterone. They can feel substantially better than they do today. Setting that expectation honestly is part of what makes the relationship work over time.
How I structure [men's hormone therapy](/services/hormone-therapy-men)
When the labs and the symptom picture support testosterone replacement, the protocol I build depends on the patient's lifestyle, sensitivity to fluctuations, and preference about route. Weekly intramuscular or subcutaneous testosterone cypionate produces stable levels with the predictability that many patients prefer. Twice-weekly subcutaneous dosing produces flatter pharmacokinetics for patients who notice the late-week trough on weekly dosing. Pellet implantation produces steady-state levels for three to five months at a time, which works well for patients with unpredictable schedules — which describes a lot of the active duty soldiers and shift workers I see across middle Georgia.
Estradiol management is a part of the protocol from day one. Testosterone aromatizes to estradiol. Some estradiol is necessary and protective — in cardiovascular health, in bone, in libido itself. Too much produces side effects (water retention, mood changes, gynecomastia in extreme cases). The right protocol monitors estradiol and adjusts only if it drifts out of range, rather than reflexively suppressing it with anastrozole the way some clinics do.
For men whose primary issue is the erectile component rather than the libido component, ED treatment can layer onto the hormone protocol. PDE5 inhibitors remain useful for the symptomatic piece. PRP-based regenerative approaches address the tissue-quality contributors when they are clinically relevant.
For couples where the partner is also experiencing perimenopausal sexual changes, the conversation often expands to include hormone optimization for her, and sometimes the O-Shot when the tissue picture warrants it. Sexual wellness is rarely a one-person problem in a long-term relationship, and treating one partner while ignoring the other tends to underperform.
What to expect on timeline
The timeline I set with patients on testosterone protocols: energy and sleep improve first, often within two to four weeks. Mood and cognitive function follow over four to eight weeks. Libido response is variable — some men notice it within the first month, others not until the second or third. Erectile function improvement, when testosterone was a meaningful contributor, tends to follow at six to twelve weeks. Body composition changes — leaner mass, less central fat — show up at three to six months when paired with appropriate resistance training. Full benefit at the calibrated dose is typically a six- to nine-month trajectory.
The patient I described at the opening of this article — total testosterone 380, free testosterone 5.6, SHBG 62, fasting insulin 16 — went through a full workup, started on a structured protocol that addressed both his testosterone and his metabolic picture, and at his six-month reassessment described feeling "like a person again." His total testosterone was at 720, his free testosterone at 19.4, his fasting insulin had come down to 8, and he had lost eighteen pounds. His libido was back. His erections were reliable. His marriage, by his own report, was the best it had been in five years.
If sexual function changes are something you have been weighing — and especially if a single lab draw and a dismissive conversation have left you unsatisfied — the next step I would recommend is a structured private consultation with the comprehensive panel I described above. Bring any prior lab work and a list of current medications. We will sit down with the data and build a protocol that addresses your actual physiology rather than a generic version of it. The conversation is private, professional, and focused on getting you to a real solution. Both the Columbus consultation and the Warner Robins location see new patients on this presentation every week.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.